Silk Road Medical, Inc (SILK)
27.49
0.00 (0.00%)
Inactive · Last trade price
on Sep 17, 2024
Silk Road Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 191.43 | 177.13 | 138.64 | 101.48 | 75.23 | 63.35 | Upgrade
|
| Revenue Growth (YoY) | 17.53% | 27.77% | 36.62% | 34.89% | 18.74% | 83.33% | Upgrade
|
| Cost of Revenue | 49.24 | 50.05 | 37.88 | 25.45 | 21.29 | 15.93 | Upgrade
|
| Gross Profit | 142.19 | 127.09 | 100.76 | 76.03 | 53.94 | 47.43 | Upgrade
|
| Selling, General & Admin | 159.71 | 145.03 | 116.32 | 96.39 | 75.52 | 63.22 | Upgrade
|
| Research & Development | 42.65 | 41.32 | 36.45 | 27.11 | 21.27 | 12.27 | Upgrade
|
| Operating Expenses | 202.37 | 186.36 | 152.77 | 123.5 | 96.8 | 75.49 | Upgrade
|
| Operating Income | -60.17 | -59.27 | -52 | -47.47 | -42.86 | -28.07 | Upgrade
|
| Interest Expense | -6.91 | -6.87 | -5.1 | -2.52 | -4.41 | -4.95 | Upgrade
|
| Interest & Investment Income | 10.03 | 9.96 | 2.53 | 0.2 | 1.1 | 1.66 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.72 | 0.65 | 0.02 | 0.01 | -0.07 | -21.05 | Upgrade
|
| EBT Excluding Unusual Items | -56.34 | -55.54 | -54.56 | -49.78 | -46.24 | -52.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.16 | -0.16 | -0.18 | -0.01 | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.25 | - | -1.12 | - | Upgrade
|
| Pretax Income | -56.5 | -55.7 | -54.98 | -49.79 | -47.35 | -52.41 | Upgrade
|
| Income Tax Expense | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Earnings From Continuing Operations | -56.54 | -55.74 | -55.01 | -49.81 | -47.37 | -52.42 | Upgrade
|
| Net Income | -56.54 | -55.74 | -55.01 | -49.81 | -47.37 | -52.42 | Upgrade
|
| Net Income to Common | -56.54 | -55.74 | -55.01 | -49.81 | -47.37 | -52.42 | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 36 | 35 | 33 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 36 | 35 | 33 | 23 | Upgrade
|
| Shares Change (YoY) | 4.37% | 8.47% | 3.29% | 5.07% | 43.60% | 2289.13% | Upgrade
|
| EPS (Basic) | -1.44 | -1.44 | -1.54 | -1.44 | -1.44 | -2.28 | Upgrade
|
| EPS (Diluted) | -1.44 | -1.44 | -1.54 | -1.44 | -1.44 | -2.28 | Upgrade
|
| Free Cash Flow | -36.08 | -33.52 | -37.59 | -43.69 | -42.91 | -30.15 | Upgrade
|
| Free Cash Flow Per Share | -0.92 | -0.86 | -1.05 | -1.26 | -1.30 | -1.31 | Upgrade
|
| Gross Margin | 74.28% | 71.75% | 72.68% | 74.92% | 71.70% | 74.86% | Upgrade
|
| Operating Margin | -31.43% | -33.46% | -37.51% | -46.78% | -56.97% | -44.30% | Upgrade
|
| Profit Margin | -29.53% | -31.47% | -39.68% | -49.09% | -62.96% | -82.73% | Upgrade
|
| Free Cash Flow Margin | -18.85% | -18.92% | -27.11% | -43.06% | -57.04% | -47.58% | Upgrade
|
| EBITDA | -57.55 | -56.58 | -49.88 | -46.44 | -42.07 | -27.35 | Upgrade
|
| EBITDA Margin | -30.06% | -31.94% | -35.98% | -45.76% | -55.92% | -43.17% | Upgrade
|
| D&A For EBITDA | 2.62 | 2.7 | 2.13 | 1.03 | 0.79 | 0.71 | Upgrade
|
| EBIT | -60.17 | -59.27 | -52 | -47.47 | -42.86 | -28.07 | Upgrade
|
| EBIT Margin | -31.43% | -33.46% | -37.51% | -46.78% | -56.97% | -44.30% | Upgrade
|
| Advertising Expenses | - | 0.46 | 0.35 | 0.22 | 0.19 | 0.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.